Induction of EAE in mice with recombinant human MOG, and treatment of EAE with a MOG peptide

被引：54

作者：

Devaux, B ^{[1
]}

Enderlin, F ^{[1
]}

Wallner, B ^{[1
]}

Smilek, DE ^{[1
]}

机构：

[1] IMMULOG PHARMACEUT CORP, WALTHAM, MA 02154 USA

来源：

JOURNAL OF NEUROIMMUNOLOGY | 1997年 / 75卷 / 1-2期

关键词：

myelin oligodendrocyte glycoprotein; experimental autoimmune encephalomyelitis; T cell epitope; peptide therapy;

D O I：

10.1016/S0165-5728(97)00019-2

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Myelin oligodendrocyte glycoprotein (MOG) is a transmembrane glycoprotein expressed on the surface of central nervous system (CNS) myelin membranes, which has been shown to induce experimental autoimmune encephalomyelitis (EAE) in rodents. Here we describe the induction of EAE in SJL and (PLJ x SJL)Fl mice with truncated human recombinant MOG (thr-MOG, amino acids 1-120) which has been expressed in insect cells in soluble form. We show that in SJL mice, immunization with thr-MOG produces an immune response to the 1-30 and the 81-110 regions of the MOG molecule. We also demonstrate effective treatment of thr-MOG-induced EAE in SJL mice with intravenous injections of a single peptide, MOG 91-110. These results support the possibility of treating MS using an antigen-dependent approach.

引用

收藏

页码：169 / 173

页数：5

相关论文

共 20 条

[1] PURIFICATION AND PARTIAL STRUCTURAL AND FUNCTIONAL-CHARACTERIZATION OF MOUSE MYELIN OLIGODENDROCYTE GLYCOPROTEIN [J].

AMIGUET, P ;

GARDINIER, MV ;

ZANETTA, JP ;

MATTHIEU, JM .

JOURNAL OF NEUROCHEMISTRY, 1992, 58 (05) :1676-1682

[2]

AMOR S, 1994, J IMMUNOL, V153, P4349

[3] Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein [J].

Brocke, S ;

Gijbels, K ;

Allegretta, M ;

Ferber, I ;

Piercy, C ;

Blankenstein, T ;

Martin, R ;

Utz, U ;

Karin, N ;

Mitchell, D ;

Veromaa, T ;

Waisman, A ;

Gaur, A ;

Conlon, P ;

Ling, N ;

Fairchild, PJ ;

Wraith, DC ;

OGarra, A ;

Fathman, CG ;

Steinman, L .

NATURE, 1996, 379 (6563) :343-346

[4] T-CELL DELETION IN HIGH ANTIGEN DOSE THERAPY OF AUTOIMMUNE ENCEPHALOMYELITIS [J].

CRITCHFIELD, JM ;

RACKE, MK ;

ZUNIGAPFLUCKER, JC ;

CANNELLA, B ;

RAINE, CS ;

GOVERMAN, J ;

LENARDO, MJ .

SCIENCE, 1994, 263 (5150) :1139-1143

[5] CHRONIC RELAPSING EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS WITH A DELAYED-ONSET AND AN ATYPICAL CLINICAL COURSE, INDUCED IN PL/J MICE BY MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)-DERIVED PEPTIDE - PRELIMINARY-ANALYSIS OF MOG T-CELL EPITOPES [J].

DEROSBO, NK ;

MENDEL, I ;

BENNUN, A .

EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (04) :985-993

[6]

FRITZ RB, 1989, CHEM IMMUNOL, V46, P101

[7] MYELIN OLIGODENDROCYTE GLYCOPROTEIN IS A UNIQUE MEMBER OF THE IMMUNOGLOBULIN SUPERFAMILY [J].

GARDINIER, MV ;

AMIGUET, P ;

LININGTON, C ;

MATTHIEU, JM .

JOURNAL OF NEUROSCIENCE RESEARCH, 1992, 33 (01) :177-187

[8] AMELIORATION OF AUTOIMMUNE ENCEPHALOMYELITIS BY MYELIN BASIC-PROTEIN SYNTHETIC PEPTIDE INDUCED ANERGY [J].

GAUR, A ;

WIERS, B ;

LIU, A ;

ROTHBARD, J ;

FATHMAN, CG .

SCIENCE, 1992, 258 (5087) :1491-1494

[9]

JOHNS TG, 1995, J IMMUNOL, V154, P5536

[10] REVERSAL OF EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS BY A SOLUBLE PEPTIDE VARIANT OF A MYELIN BASIC-PROTEIN EPITOPE - T-CELL RECEPTOR ANTAGONISM AND REDUCTION OF INTERFERON-GAMMA AND TUMOR-NECROSIS-FACTOR-ALPHA PRODUCTION [J].

KARIN, N ;

MITCHELL, DJ ;

BROCKE, S ;

LING, N ;

STEINMAN, L .

JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (06) :2227-2237